UNSPSC 85763004: Revision of autologous tissue substitute in lower back, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in lower back, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0WWL37Z

UNSPSC 85763004 Revision of autologous tissue substitute in lower back, percutaneous approach (Commodity) does not align with recent state and local procurement activity. The code nominally describes a specific surgical procedure code used in clinical settings, but the recent opportunities posted under this code—independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical benefit carve-outs, specialty medical staffing, and youth detention healthcare—reflect administrative healthcare procurement, health plan management, and clinical staffing services that fall outside the scope of autologous tissue revision procedures. The mismatch suggests a tagging or classification error in the source data rather than genuine procurement demand under this Commodity code.

No meaningful recent state and local procurement activity exists for autologous tissue revision procedures themselves under this code. The opportunities posted (Phoenix Retirement Office disability medical evaluation RFP due October 16, 2026; Long Beach surgical benefit carve-out RFP due October 7, 2026; Washington State Ferries occupational medical surveillance RFP due October 9, 2026; Santa Clara Health System temporary health professional staffing RFQ due October 7, 2026; and Collier County pharmacy benefit management RFP with April 9, 2026 deadline) represent healthcare administration and staffing procurement across Arizona, California, Florida, and Washington, not procedural or implant procurement aligned with the code's stated scope. Pursuing opportunities under this code requires clarifying whether the issuing jurisdictions intend to solicit clinical procedure or implant services or whether the code assignment reflects a data-entry error.